Osteoarthritis
Fluticasone propionate injection improves osteoarthritis knee pain over 12 weeks
EP-104AR, an injectable form of fluticasone propionate designed slowly distribute through the knee joint and provide pain relief for up to 6 months, improved pain vs. a placebo over 12 weeks, according to the manufacturer.
Rheumatologists must ‘balance’ flare, infection risks in hip, knee replacement
SAN DIEGO — Mitigating infection risks while preventing flares is often a balancing act for rheumatologists managing patients undergoing hip or knee replacement, according to a presenter at the 2023 Congress of Clinical Rheumatology West.
‘A call to action’: Assessing OA risk factors critical as cases to reach 1 billion by 2050
SAN DIEGO — The ability to recognize common osteoarthritis risk factors will become increasingly critical in the coming decades, as recent data project the global prevalence of the disease will reach 1 billion by 2050, noted a speaker here.
Osteoarthritis expected to impact nearly 1 billion people by 2050
Nearly 1 billion people will be burdened with osteoarthritis by 2050, according to data published in The Lancet Rheumatology.
The Congress of Clinical Rheumatology-West goes ‘Back to the Future’ in San Diego
Highlights of the upcoming 2023 Congress of Clinical Rheumatology-West include a talk on what the rheumatology field will look like in a decade, according to David A. McLain, MD, symposium director for the meeting.
Patients with worse osteoarthritis pain, physical function benefit most from exercise
Patients with hip or knee osteoarthritis who exercise fare better than patients who do not, with those demonstrating worse severity and function at baseline benefitting most acutely, according to data published in The Lancet Rheumatology.
Lifestyle-based strategies ‘unlikely’ to improve exercise adherence in osteoarthritis
Strategies encouraging physical activity that are based on lifestyle, demographic, socioeconomic and disease-related factors are “unlikely” to improve exercise adherence among patients with osteoarthritis, according to data.
‘Substantial portion’ of patients with hip osteoarthritis report sexual dissatisfaction
A “substantial portion” of patients with hip osteoarthritis say their disease interferes with their sexual activity, with depression among the leading factors, according to data published in the International Journal of Rheumatic Diseases.
A ‘mismatch of information’: Exercising with osteoarthritis a matter of hurt vs. harm
As a seemingly ever-increasing body of data support physical activity in patients with osteoarthritis, a growing discussion is addressing the distinction between pain and harm, and how the two are experienced by those with the disease.
Patients receiving levothryxine more likely to lose muscle mass, exhibit higher OA risk
Patients treated with levothroxine are more likely to experience a reduction in quadricep muscle mass, which may increase the risk for knee osteoarthritis, according to data published in Arthritis Research & Therapy.